Vanberra Signal

Dropprint Genomics

Curated by Signal

Developer of genomics data sets for drug discovery

Overview

Dropprint Genomics is developing single-cell technology to profile gene data sets for the development of drugs for immune-based diseases. The company uses its single-cell technology and machine learning models to identify gene data sets and characterize the data from large populations for understanding the immune system.

Key facts

Founded
2019

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of nutritional supplements for prenatal care

    Life Sciences TechnologyLos Angeles, United States
  • Provider of computational tools for metabolic engineering

    Life Sciences TechnologySaint Paul, United States
  • Personal microbiome monitoring device

    Life Sciences TechnologyCampbell, United States

About Dropprint Genomics

What does Dropprint Genomics do?

Dropprint Genomics is developing single-cell technology to profile gene data sets for the development of drugs for immune-based diseases.

Where is Dropprint Genomics headquartered?

Dropprint Genomics is headquartered in San Francisco, United States.

When was Dropprint Genomics founded?

Dropprint Genomics was founded in 2019.

Which sector is Dropprint Genomics in?

Dropprint Genomics operates in Life Sciences Technology.

Who are Dropprint Genomics's competitors?

Companies similar to Dropprint Genomics include Needed, Genome Craft, and Floragraph.